Skip to Content
Søk Menu

Jan Andreasen

Jan Andreasen is an educated doctor and journalist. He serves as the editor-in-chief of BestPractice Nordic in Denmark, Norway, Sweden, and Finland, and he has been involved in the dissemination of new knowledge within the field of medical science for over 25 years

Articles and MEDtalks

First-Line NSCLC Without Driver Mutations: Practice, Gaps, and Costs

  • / Ronny Öhman / Jan Andreasen

Verna: Lung Cancer Insights: What’s New in the Field

/ Jan Andreasen / Amanda Feldballe Bernholm

AML Insights – June Update: What’s New in the Field

/ Jan Andreasen
AML

Nordic AML Insights – June Update: Research and EHA Congress

/ Jan Andreasen
AML

EAN 2025: GPT-4o Can’t Replace Doctors – But It Can Reduce Delays and Streamline the Treatment Process

/ Jan Andreasen
EAN25

EHA 2025: Improved Outcomes in High-Risk MCL with Acalabrutinib Combination Therapy 

/ Jan Andreasen
EHA25

Toward a New Standard of Care: Sacituzumab and Pembrolizumab in PD-L1+ mTNBC

/ Jan Andreasen
ASCO25NBCN

Nordic AML Insights: Research and Ph.D. Contributions

/ Jan Andreasen
AML

AML Insights: What’s New in the Field

/ Jan Andreasen
AML

Lazertinib + Amivantamab: A New Chemotherapy-Free Option for EGFR-Mutated Advanced NSCLC

/ Antonio Passaro / Jan Andreasen
Lungekreft

Fredrik Schjesvold: Bridging Science and Clinical Innovation                                                                                 

/ Jan Andreasen
Myelomatose
Load more
Back to top